Marshall Financial Group (Pennsylvania)’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,653
Closed -$30.5K 50
2023
Q2
$30.5K Hold
1,653
0.01% 49
2023
Q1
$47.9K Hold
1,653
0.02% 50
2022
Q4
$45.9K Hold
1,653
0.02% 50
2022
Q3
$91K Hold
1,653
0.04% 52
2022
Q2
$91K Hold
1,653
0.04% 53
2022
Q1
$61K Hold
1,653
0.02% 56
2021
Q4
$40K Hold
1,653
0.02% 58
2021
Q3
$74K Hold
1,653
0.03% 59
2021
Q2
$77K Buy
1,653
+666
+67% +$34K 0.03% 57
2021
Q1
$55K Hold
987
0.03% 55
2020
Q4
$61K Hold
987
0.03% 55
2020
Q3
$58K Hold
987
0.03% 52
2020
Q2
$110K Hold
987
0.07% 50
2020
Q1
$66K Buy
+987
New +$99.4K 0.05% 44

Other funds holding OPTN

Marshall Financial Group (Pennsylvania)'s OPTN Position: Q3 2023 in Review

Marshall Financial Group (Pennsylvania) sold out of OptiNose (OPTN) in Q3 2023, closing a stake of 1,653 shares — an estimated $30.5K sold.

Marshall Financial Group (Pennsylvania) first reported a position in OPTN in Q1 2020 and held it in 14 quarters. The position peaked at $110K in Q2 2020. 60 funds tracked by Wall St. Rank hold OPTN as of Q3 2023.

  • Marshall Financial Group (Pennsylvania) reported no remaining OptiNose position as of Q3 2023 after selling out during the quarter.
  • Marshall Financial Group (Pennsylvania) sold 1,653 OptiNose shares in Q3 2023, an estimated $30.5K.
  • Marshall Financial Group (Pennsylvania) first reported a position in OptiNose in Q1 2020 and held it in 14 quarters.
  • Marshall Financial Group (Pennsylvania)'s OptiNose position peaked at $110K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held OptiNose as of Q3 2023.

Based on Marshall Financial Group (Pennsylvania)'s 13F filing for Q3 2023, filed 3 Nov 2023.